BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2026 7:34:31 AM | Browse: 62 | Download: 405
Publication Name Artificial Intelligence in Gastroenterology
Manuscript ID 120311
Country India
ISSN 2644-3236 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Artificial intelligence in prognostication and treatment response modeling in advanced hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Babu Lal Meena, Bijaylaxmi Behera, Omkar S Rudra and Deepti Sharma
ORCID
Author(s) ORCID Number
Babu Lal Meena http://orcid.org/0000-0002-7019-1020
Deepti Sharma http://orcid.org/0000-0002-9911-3384
Funding Agency and Grant Number
Corresponding Author Babu Lal Meena, Department of Hepatology, Postgraduate Institute of Medical Education and Research, -, Chandigarh 160012, India. drbabupgi@gmail.com
Key Words Artificial intelligence; Hepatocellular carcinoma; Radiomics; Prognostic modeling; Predictive modeling; Survival analysis; Causal inference; Precision oncology
Core Tip Artificial intelligence models in advanced hepatocellular carcinoma frequently demonstrate improved discrimination compared with conventional staging systems; however, most remain retrospective, prognostic rather than predictive, and inconsistently validated across institutions and therapeutic eras. This review critically distinguishes statistical performance gains from clinically meaningful advancement, emphasizing the need for causal modeling, competing-risk adaptation, calibration assessment, and prospective decision-impact evaluation before routine integration into multidisciplinary hepatology practice.
Publish Date 2026-08-06 07:34
Citation

Meena BL, Behera B, Rudra OS, Sharma D. Artificial intelligence in prognostication and treatment response modeling in advanced hepatocellular carcinoma. Artif Intell Gastroenterol 2026; 7(2): 120311

URL https://www.wjgnet.com/2644-3236/full/v7/i2/120311.htm
DOI https://doi.org/10.35712/aig.120311
Full Article (PDF) AIG-7-120311-with-cover.pdf